To study the pathogenesis of CADASIL through comprehensive clinical evaluations and molecular studies on biospecimens collected under this protocol from affected and unaffected cohorts (as reference biospecimens).

Clinical evaluations will be used to determine whether disease progression can be assessed.

20

All

18 Years to 100 Years (Adult, Senior)

NCT02821780

16013216-H-0132

June 29, 2016

April 6, 2020

April 6, 2020

July 4, 2016

March 2, 2018

National Institutes of Health Clinical CenterBethesda, Maryland, United States